Addiction

Stanford Medicine and Harvard researchers found that buprenorphine for opioid use disorder treatment during pregnancy was linked to better outcomes for newborns than methadone.

In a new clinical trial, Stanford Medicine researchers found that a commonly used anti-nausea drug could reduce the severity of opioid withdrawal in newborns.

Robert Malenka’s early research on the molecular mechanisms underlying memory and learning has led to an understanding of their role in psychiatric disorders including addiction, depression and autism spectrum disorder.

The opioid epidemic is projected to claim 1.22 million U.S. lives this decade without new efforts to stem the crisis, according to a report that traces the roots of the problem and offers in-depth solutions.

A Stanford researcher and two collaborators conducted an extensive review of Alcoholics Anonymous studies and found that the fellowship helps more people achieve sobriety than therapy does.